ArticleCureus2026

An In-Field Recurrent Cervical Cancer Case After Chemoradiotherapy With a Marked Response to Pembrolizumab Combined With TC (Paclitaxel-Carboplatin) Therapy: A Case Report.

Terumi Shirane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.